Neuroone Medical Technologies (NMTC) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.96% |
| Dec 31, 2025 | -3.88% |
| Sep 30, 2025 | -5.60% |
| Jun 30, 2025 | -2.21% |
| Mar 31, 2025 | -31.86% |
| Dec 31, 2024 | -27.70% |
| Sep 30, 2024 | -12.22% |
| Jun 30, 2024 | -20.59% |
| Mar 31, 2024 | -23.22% |
| Dec 31, 2023 | -9.72% |
| Sep 30, 2023 | 19.38% |
| Jun 30, 2023 | 8.87% |
| Mar 31, 2023 | 73.10% |
| Dec 31, 2022 | 53.73% |
| Sep 30, 2022 | 188.75% |
| Jun 30, 2022 | 96.03% |
| Mar 31, 2022 | 76.21% |
| Dec 31, 2021 | 209.87% |
| Sep 30, 2021 | 231.09% |
| Jun 30, 2021 | 249.53% |
| Mar 31, 2021 | 265.65% |
| Dec 31, 2020 | 216.33% |
| Sep 30, 2020 | 160.97% |
| Dec 31, 2019 | 52.01% |
| Sep 30, 2019 | 399.37% |
| Jun 30, 2019 | 610.82% |
| Mar 31, 2019 | 1,023.42% |
| Dec 31, 2018 | 579.85% |
| Dec 31, 2017 | 968.37% |
| Dec 31, 2016 | 1,029.71% |
| Sep 30, 2016 | 91.61% |
| Jun 30, 2016 | 47.31% |
| Mar 31, 2016 | -29.27% |
| Dec 31, 2015 | 18.02% |
| Dec 31, 2014 | -75.45% |
| Jun 30, 2014 | 33.63% |
| Dec 31, 2013 | -61.40% |